Skip to Content

Vincristine Sulfate Injection

Last Updated: February 7, 2018
Status: Current

Vincristine Sulfate Injection

Products Affected - Description
  • Vincasar injection, Teva
    1 mg/mL, 1 mL vial, 1 count (NDC 00703-4402-11)
    1 mg/mL, 2 mL vial, 1 count (NDC 00703-4422-11)


Vincristine injection, Pfizer
1 mg/mL, 1 mL vial, 1 count (NDC 61703-0309-06)
1 mg/mL, 2 mL vial, 1 count (NDC 61703-0309-16)
Reason for the Shortage
    • Pfizer has vincristine on shortage due to manufacturing delays.
    • Teva has Vincasar on shortage due to increased demand.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Pfizer has vincristine 1 mg/mL 1 mL and 2 mL vials on back order and the company estimates a release date of late-February 2018 for the 1 mL vials and March 2018 for the 2 mL vials.
    • Teva has Vincasar 1 mg/mL 1 mL and 2 mL vials on allocation. Check wholesaler for availability.

Updated

February 7, January 27, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide